![](https://investorshub.advfn.com/uicon/158678.png?cb=1661594561)
Saturday, October 16, 2021 8:12:19 AM
It's an SEC filing. It gets filed with the SEC (not released to OTC) and it was filed within the 4 day SEC requirement for filing.
"On October 10, 2021, the Compensation Committee and Board of Directors of Innovation Pharmaceuticals Inc. (the “Company”) approved the following matters:"
I guess they work on Sunday in Boca. Or do they just date stuff on Sunday?
From the latest 10K (and probably the last 4 or 5 10Ks):
"The Board has adopted written charters for each of its committees which are available on the Company’s website at http://www.ipharminc.com."
"The Compensation Committee did not hold any meeting in fiscal 2021. The Compensation Committee consists of Dr. Barry Schechter and Dr. Zorik Spektor, each of whom is “independent” as that term is defined under the Nasdaq Listing Rules."
From the Compensation Committee Charter, linked above:
COMPOSITION
The Committee shall consist of at least three (3) members of the Board.
It's an interesting read if you have the time.
BTW the three Committees and their Charters were created in September and October of 2015 for a single purpose...to secure a Nasdaq listing. If one were to argue that the failure to secure that listing negates any requirement to follow Nasdaq rules (which require, for example, a 3 independent director Audit Committee) they would be correct. But there are no rules and no rhyme or reason that exist to allow for filing a 10K that points the investing public to Company Charters that the Company itself is not conforming to.
The third independent director, Mark R. Tobin resigned on December 31, 2018.
As my dear old grandfather Litvak said (just before they swung the trap), he said "You can't cheat an honest man. Never give a sucker an even break or smarten up a chump."
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM